Procurement Kidney Biopsy and Donor Clinical Risk as Complementary Tools to Predict 3‐ and 12‐Month Graft Function After Transplantation
Clinical Transplantation · 2025
DOI: 10.1111/ctr.70421 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Transplantation, 2025. Verfasst von Henrique M S Proença und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Do Rim, Fundação Oswaldo Ramos, São Paulo, Brazil. Hauptthemen laut MEDLINE: Kidney Transplantation, Graft Rejection, Tissue and Organ Procurement, Tissue Donors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Background
Procurement kidney biopsy has been used for over two decades, yet its value in guiding graft acceptance and allocation decisions remains debated. This study evaluated the performance of procurement biopsies in predicting kidney graft function within the first‐year post‐transplantation.
Methods
Retrospective cohort study including 339 procurement biopsies of kidneys transplanted between May 2018 and August 2019. All biopsies were paraffin embedded, stained (H&E, PAS, Jones Silver, and Masson's Trichrome), and prospectively analyzed and deemed suitable for transplantation by an experienced renal pathologist. All biopsies were retrospectively scored according to the Banff, Remuzzi, and MAPI classifications. Logistic regression was used to identify clinical and histological variables associated with unsatisfactory graft function, defined as eGFR
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hospital Do Rim, Fundação Oswaldo Ramos, São Paulo, Brazil.
- Nephrology Division, Universidade Federal de São Paulo, São Paulo, Brazil.
- Faculdade De Medicina do ABC, Santo André, São Paulo, Brazil.
ORCID-Profile: Henrique M S Proença, Lúcio Requião-Moura, Nicolas K Melaragno, Renato D Foresto, Jose O Medina Pestana, Helio Tedesco-Silva
Zitieren
APA
Proença, H. M. S., Requião-Moura, L., Melaragno, N. K., Foresto, R. D., Pestana, J. O. M., & Tedesco-Silva, H. (2025). Procurement Kidney Biopsy and Donor Clinical Risk as Complementary Tools to Predict 3‐ and 12‐Month Graft Function After Transplantation. Clinical Transplantation. https://doi.org/10.1111/ctr.70421
Vancouver
Proença HMS, Requião-Moura L, Melaragno NK, Foresto RD, Pestana JOM, Tedesco-Silva H. Procurement Kidney Biopsy and Donor Clinical Risk as Complementary Tools to Predict 3‐ and 12‐Month Graft Function After Transplantation. Clinical Transplantation. 2025. doi:10.1111/ctr.70421
BibTeX
@article{Proena2025,
author = {Proença, Henrique M S and Requião-Moura, Lúcio and Melaragno, Nicolas K and Foresto, Renato D and Pestana, Jose O Medina and Tedesco-Silva, Helio},
title = {Procurement Kidney Biopsy and Donor Clinical Risk as Complementary Tools to Predict 3‐ and 12‐Month Graft Function After Transplantation},
journal = {Clinical Transplantation},
year = {2025},
doi = {10.1111/ctr.70421}
}
EUVIMED